FDAsafety guidance66% confidence
FDA AP — TRETINOIN (ORIG)
Source: FDA
Why This Matters
Why this matters: provides agency context on safety guidance that may shape timing or evidence expectations for Alembic Pharmaceuticals; the same agency is already in play for this signal, so precedent weight is higher.
Regulatory Analysis
Application ANDA217497. Sponsor: AMNEAL. Submission status: AP. Submission type: ORIG. Review priority: STANDARD. Active ingredients: TRETINOIN.
Supporting Context
- Therapeutic area
- Dermatology · Acne
- Sub-indication
- General
Related signal: FDA Grants Approval for Tretinoin ANDA214590 by Alembic